Descriptive analysis of the production of occlusal devices for the treatment of Temporomandibular Disorder by the Brazilian public health system

ABSTRACT

BACKGROUND AND OBJECTIVES  Temporomandibular dysfunction (TMD) has a significant prevalence in the population, and many individuals with this dysfunction depend exclusively on the Brazilian public health system (SUS). Thus, the aim of this study was to analyze the production of occlusal devices (ODs) as treatment for TMD, offered to SUS users from 2014 to 2023.

METHODS  Secondary data from the SUS Outpatient Information System (SIASUS) were used and tabulated using the TAB software for Windows (TabWin), using code 0701070072 (occlusal splint). Information was collected on the quantity and total cost of production of ODs in Brazil and grouped into the variables states, geographic regions, sex and age. The data were presented descriptively.

RESULTS  A total of 26,006 ODs were produced in the country over between the years 2014 and 2022, representing a total cost of R$612,181.24. Most ODs (76%) were intended for female patients with an average age of 41.23 years. The states of São Paulo and Ceará had the highest production, while some states had no records. The production of ODs varied over the 10 years analyzed, with a large reduction during the COVID-19 pandemic period and a resumption from 2022 onward.

CONCLUSION  The data suggest insufficient production of ODs, which constitute one of the most common therapeutic modalities for TMD. Discrepancies between states demonstrated concentration in some regions and lack of access in others. The implementation of specific public health policies for this dysfunction could expand access for SUS users and reduce regional inequalities.

Keywords:
Costs and cost analysis; Dental health services; Temporomandibular joint dysfunction syndrome; Unified Health System

HIGHLIGHTS

The production of occlusal devices in SUS, Brazilian public health system, has been concentrated in a few states, with no records in others

The occlusal device has been produced mainly for female patients

Public policies need to be implemented in order to increase access to treatment for Temporomandibular Dysfunction and Orofacial Pain and reduce regional inequalities